MEDIPAL HOLDINGS CORP.
Research MEDIPAL HOLDINGS CORP. (59Z) on Bullrun: market cap EUR 3.09B, P/E 13.5, dividend yield 2.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker59Z
- ExchangeF
- CountryJapan
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyEUR
- Market capEUR 3.09B
- P/E13.5
- Dividend yield2.4%
- Financial periodFY2026
- RevenueJPY 3.82T
- Revenue growth4.0%
- Net incomeJPY 42.53B
- Free cash flowJPY 36.87B
- Gross margin6.8%
Valuation Snapshot
latest market cap is EUR 3.09B; P/E is 13.5; dividend yield is 2.4%.
Peer valuation comparison
Latest P/E is 13.48x versus a Healthcare sector median of 24.46x (44.9% below).
Latest dividend yield is 2.37% versus a Healthcare sector median of 2.11% (12.3% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 3.82T | JPY 42.53B | JPY 36.87B | 6.8% | 206.67 | JPY 289.07B | n/a | JPY 652.17B |
| FY2025 | JPY 3.67T | JPY 40.28B | JPY 48.13B | 7.0% | 193.2 | JPY 261.41B | n/a | JPY 619.56B |
| FY2024 | JPY 3.56T | JPY 41.47B | JPY 42.45B | 6.9% | 195.83 | JPY 230.15B | n/a | JPY 600.35B |
| FY2023 | JPY 3.36T | JPY 38.81B | JPY 2.64B | 6.7% | 179.12 | JPY 195.03B | JPY 0 | JPY 561.36B |
| FY2022 | JPY 3.29T | JPY 29.42B | JPY 42.34B | 6.6% | 131.41 | JPY 243.15B | JPY 30.08B | JPY 530.30B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-14 | EUR 3.09B | 13.5 | 3.1% | 0.48 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.48 EUR, yield 2.4%.
| Year | Dividends/share |
|---|---|
| FY2026 | 0.19 JPY |
| FY2025 | 0.35 JPY |
| FY2024 | 0.33 JPY |
| FY2023 | 0.29 JPY |
| FY2022 | 0.25 JPY |
About MEDIPAL HOLDINGS CORP.
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprising medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is MEDIPAL HOLDINGS CORP.'s market cap?
MEDIPAL HOLDINGS CORP.'s market capitalization is EUR 3.09B.
What is MEDIPAL HOLDINGS CORP.'s P/E ratio?
MEDIPAL HOLDINGS CORP.'s price-to-earnings (P/E) ratio is 13.5.
Does MEDIPAL HOLDINGS CORP. pay a dividend?
MEDIPAL HOLDINGS CORP. has a dividend yield of 2.4%.
What does MEDIPAL HOLDINGS CORP. do?
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprising medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products.